1. Home
  2. ODC vs AKBA Comparison

ODC vs AKBA Comparison

Compare ODC & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ODC
  • AKBA
  • Stock Information
  • Founded
  • ODC 1941
  • AKBA 2007
  • Country
  • ODC United States
  • AKBA United States
  • Employees
  • ODC N/A
  • AKBA N/A
  • Industry
  • ODC Miscellaneous manufacturing industries
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ODC Consumer Discretionary
  • AKBA Health Care
  • Exchange
  • ODC Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • ODC 853.6M
  • AKBA 958.6M
  • IPO Year
  • ODC N/A
  • AKBA 2014
  • Fundamental
  • Price
  • ODC $57.37
  • AKBA $3.68
  • Analyst Decision
  • ODC
  • AKBA Strong Buy
  • Analyst Count
  • ODC 0
  • AKBA 5
  • Target Price
  • ODC N/A
  • AKBA $6.90
  • AVG Volume (30 Days)
  • ODC 55.6K
  • AKBA 6.6M
  • Earning Date
  • ODC 06-05-2025
  • AKBA 08-07-2025
  • Dividend Yield
  • ODC 1.26%
  • AKBA N/A
  • EPS Growth
  • ODC 17.38
  • AKBA N/A
  • EPS
  • ODC 3.40
  • AKBA N/A
  • Revenue
  • ODC $474,062,000.00
  • AKBA $184,909,000.00
  • Revenue This Year
  • ODC N/A
  • AKBA $26.88
  • Revenue Next Year
  • ODC N/A
  • AKBA $44.34
  • P/E Ratio
  • ODC $17.06
  • AKBA N/A
  • Revenue Growth
  • ODC 9.92
  • AKBA N/A
  • 52 Week Low
  • ODC $29.47
  • AKBA $0.80
  • 52 Week High
  • ODC $60.32
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • ODC 61.91
  • AKBA 63.81
  • Support Level
  • ODC $55.36
  • AKBA $3.48
  • Resistance Level
  • ODC $60.31
  • AKBA $3.87
  • Average True Range (ATR)
  • ODC 2.24
  • AKBA 0.24
  • MACD
  • ODC -0.05
  • AKBA -0.04
  • Stochastic Oscillator
  • ODC 72.41
  • AKBA 35.71

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: